IWMPD
MCRB icon

Integrated Wealth Management (Palm Desert)’s Seres Therapeutics MCRB Stock Holding History

Integrated Wealth Management (Palm Desert)’s Portfolio MCRB Stock Details MCRB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-15
Closed -$12K – 1349
2015
Q2 		$12K Buy
+15
New +$13.1K ﹤0.01% 747

Other funds holding MCRB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
FV2GP
Flagship Ventures 2007 General Partner Cambridge, Massachusetts $107M AUM
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $6.8B AUM 45.85% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
BA
BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Integrated Wealth Management (Palm Desert)'s MCRB Position: Q3 2015 in Review

Integrated Wealth Management (Palm Desert) sold out of Seres Therapeutics (MCRB) in Q3 2015, closing a stake of 15 shares — an estimated $12K sold.

Integrated Wealth Management (Palm Desert) first reported a position in MCRB in Q2 2015 and held it in 1 quarter. The position peaked at $12K in Q2 2015. 60 funds tracked by Wall St. Rank hold MCRB as of Q3 2015.

  • Integrated Wealth Management (Palm Desert) reported no remaining Seres Therapeutics position as of Q3 2015 after selling out during the quarter.
  • Integrated Wealth Management (Palm Desert) sold 15 Seres Therapeutics shares in Q3 2015, an estimated $12K.
  • Integrated Wealth Management (Palm Desert) first reported a position in Seres Therapeutics in Q2 2015 and held it in 1 quarter.
  • Integrated Wealth Management (Palm Desert)'s Seres Therapeutics position peaked at $12K in Q2 2015.
  • 60 funds tracked by Wall St. Rank held Seres Therapeutics as of Q3 2015.

Based on Integrated Wealth Management (Palm Desert)'s 13F filing for Q3 2015, filed 13 Oct 2015.